Therapeutic Goods Amendment (2017 Measures No. 1) Bill 2017
Became law
| Act | Therapeutic Goods Amendment (2017 Measures No. 1) Act 2018 |
|---|---|
| Number | No. 7, 2018 |
| Assent | 5 Mar 2018 |
| Status | In force |
Sourced from the Federal Register of Legislation at 21 Nov 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.
Progress
| Date | Step |
|---|---|
| House | |
| 14 Sep 2017 | Introduced and read a first time |
| 14 Sep 2017 | Second reading moved |
| 25 Oct 2017 | Second reading debate |
| 25 Oct 2017 | Referred to Federation Chamber |
| 4 Dec 2017 | Second reading debate |
| 4 Dec 2017 | Second reading agreed to |
| 4 Dec 2017 | Reported from Federation Chamber |
| 4 Dec 2017 | Third reading agreed to |
| Senate | |
| 4 Dec 2017 | Introduced and read a first time |
| 4 Dec 2017 | Second reading moved |
| 5 Feb 2018 | Second reading debate |
| 15 Feb 2018 | Second reading debate |
| 15 Feb 2018 | Second reading agreed to |
| 15 Feb 2018 | Committee of the Whole debate |
| 15 Feb 2018 | Third reading agreed to |
| House | |
| 15 Feb 2018 | Consideration of Senate message |
| 15 Feb 2018 | Finally passed both Houses |
| 5 Mar 2018 | Assent |
Introduced with the Therapeutic Goods (Charges) Amendment Bill 2017, the bill amends the: Therapeutic Goods Act 1989 to:
- introduce a new approval pathway for prescription medicines by creating a class of therapeutic good to be known as ‘provisionally registered goods’
- allow the minister to specify, by legislative instrument, permitted indications for use with listed medicines
- establish an additional pathway for intermediate risk medicines through a new application and assessment process for sponsors of listed complementary medicines seeking to use indications that fall outside the permitted indications list
- strengthen monitoring powers in relation to biologicals
- implement stronger compliance and enforcement powers and graduated penalties for non-compliant behaviours
- remove the distinctions between advertisements for therapeutic goods for which an approval is, or is not, required
- enable the secretary to utilise the work of comparable overseas regulators in the course of making assessments of medical devices
- enable the secretary to publish information in relation to Australian conformity assessment bodies
- align the secretary’s powers relating to conformity assessment certificates issued by Australian conformity assessment bodies and conformity assessment certificates issued by the secretary
- clarify that the secretary has the power to refuse an application for including medicines, biologicals and medical devices in the Australian Register of Therapeutic Goods prior to evaluating the application if it does not meet the application requirements
- make minor amendments to achieve consistency of regulatory requirements between different types of therapeutic goods and make other minor changes
- Broadcasting Services Act 1992 to make consequential amendments.
Summary from the official bill homepage.
Documents
Official record: bill homepage at aph.gov.au, full text and documents on ParlInfo.